Group 1 - BioSyent Inc. will report its financial results for Q4 and the full year ended December 31, 2025 on March 19, 2026 after market hours [1] - A presentation by René Goehrum, President and CEO, will be available on the company's website on the same date [1] - BioSyent is a profitable growth-oriented specialty healthcare company focused on acquiring or in-licensing, marketing, and distributing innovative pharmaceutical and oral health products [2] Group 2 - The company has 11,497,447 common shares outstanding as of the date of the press release [3] - For financial information and market quotes, the company directs to visit www.tmxmoney.com [3] - Contact information for further inquiries includes Mr. René C. Goehrum, President and CEO, with an email and phone number provided [4]
BioSyent Schedules Fourth Quarter and Full Year 2025 Earnings Release for March 19, 2026
Globenewswire·2026-03-12 21:30